Consistent ART adherence is associated with improved quality of life, CD4 counts, and reduced hospital costs in central China

AIDS Research and Human Retroviruses

Volumn 25, Issue 8, 2009, Pages 757-763

  Wang, Honghong ^a   Zhou, Jun ^a   He, Gouping ^a   Luo, Yang ^a   Li, Xianhong ^a   Yang, Aiyun ^a   Fennie, Kristopher ^b   Williams, Ann B ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CHINA; FEMALE; HEALTH STATUS; HOSPITAL ADMISSION; HOSPITAL COST; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENTAL HEALTH; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; SELF REPORT; SHORT FORM 36; SOCIAL INTERACTION; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADULT; AGED; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CHINA; FEMALE; HIV; HIV INFECTIONS; HOSPITAL COSTS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; QUALITY OF LIFE; TIME FACTORS;

EID: 70349197991     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2008.0173     Document Type: Article

References (40)

1. MOH=UNAIDS=WHO: A joint assessment of HIV=AIDS prevention, treatment and care in China (2007). Beijing: Chinese Ministry of Health, 2007.
2. Gill B and Okie S: China and HIV-A window of opportunity. N Engl J Med 2007;356:1801-1805.
3. Zhang F, Haberer JE, Wang Y, et al.: The Chinese free antiretroviral treatment program: Challenges and responses. AIDS 2007;21:S143-S148.
4. Wu Z, Sullivan SG, Wang Y, Rotheram-Borus MJ, and Detels R: Evolution of China's response to HIV=AIDS. Lancet 2007; 369:679-690.
5. Zhang F, Wen Y, Yu L, Ma Y, Pan J, and Zhao Y: Antiretroviral therapy for HIV=AIDS and current situation of China free ARV program. Sci Technol Rev 2005;23:24-28.
6. Cao YZ and Lu HZ: Care of HIV patients in China. Cell Res 2005;15:883-890.
7. Aloisi MS, Arici C, Balzano R, et al.: Behavioral correlates of adherence to antiretroviral therapy. J Acquir Immune Defic Syndr 2002;31:s145-s148.
8. Laniece I, Ciss M, Desclaux A, et al.: Adherence to HAART and its principal determinants in a cohort of Senegalese adults. AIDS 2003;17:S103-S108.
9. Nieuwkerk PT and Oort FJ. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virological treatment response. J Acquir Immune Defic Syndr 2005;38: 445-448.
10. Mannheimer SB, Matts J, Telzak E, et al.: Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care 2005;17(1):10-22.
11. Nosyk B, Sun H, Li X, et al.: Highly active antiretroviral therapy and hospital readmission: Comparison of a matched cohort. BMC Infect Dis 2006;6:146-152.
12. Munakata J, Benner JS, Becker S, Dezii CM, Hazard EH, and Tierce JC: Clinical and economic outcomes of nonadherence to highly active antiretroviral therapy in patients with human immunodeficiency virus. Med Care 2006;44: 893-899.
13. Wang X and Wu Z: Factors associated with adherence to antiretroviral therapy among HIV=AIDS patients in rural China. AIDS 2007;21:S149-S155.
14. Wang H, He G, Li X, et al.: Self-reported adherence to antiretroviral treatment among HIV-infected people in central China. AIDS Patient Care STDs 2008;22: 71-79.
15. Li L, Lei J, Wang W, Jiang J, and Li X: A case-control study of infiuential factors on clinical compliance of community-based or family-based antiretroviral therapy of AIDS. Chin J AIDS=STD 2005;11:50-51, 53.
16. Wang FX and Dong FG: Follow-up for 123 AIDS patients with free anti-HIV treatment. Shan xi yi yao za zhi 2005;34: 295.
17. Yu L, Dou Z, Qu S, Zhang F, Wen Y, and Zhao Y: Adherence effects on CD4 increase rate in HAART for AIDS patients. China J AIDS=STD 2005;11:255-257.
18. Mannheimer S, Friedland G, Matts J, et al.: The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis 2002;34:1115-1121.
19. Giordano TP, Guzman D, and Clark R: Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials 2004;5(2):74-79.
20. Paterson DL, Swindells S, and Mohr J, et al.: Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.
21. Gebo KA, Keruly J, and Moore RD: Association of social stress, illicit drug use, and health beliefs with nonadherence to antiretroviral therapy. J Gen Intern Med 2003;18:104-411.
22. Bangsberg DR, Perry S, Charlebois ED, et al.: Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS 2001;15:1181-1183.
23. Carrieri P, Spire B, Duran S, et al.: Health-related quality of life after 1 year of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2003;32:38-47.
24. Protopopescu C, Marcellin F, Spire B, et al.: Health-related quality of life in HIV-1-infected patients on HAART: A five years longitudinal analysis accounting for dropout in the APROCO-COPILOTE cohort (ANRS CO-8). Qual Life Res 2007;10:1007-1015.
25. Li N, Liu C, Li J, and Ren X: Referential values of SF-36 scores in urban and rural citizens in Sichuan province. J Sichuan Univ (Medical Science Edition) 2001;32:43-47.
26. Gao X, Nau DP, Rosenbluth SA, and Scott V: The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care 2000;12:387-398.
27. Deschamps AE, Graeve VD, Vijnga VD, et al.: Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using medication event monitoring system. AIDS Patient Care STDs 2004;18:644-657.
28. Melbourne KM, Geletko SM, Brown SL, Willey-Lessne C, Chase S, and Fisher A: Medication adherence in patients with HIV infection: A comparison of two measurement methods. AIDS Read 1999;9:329-338.
29. Tesoriero J, French T, Weiss L, Waters M, Finkelstein R, and Agins B: Stability to highly antiretroviral therapy over time among clients enrolled in the treatment adherence demonstration project. J Acquir Immune Defic Syndr 2003;33:484-493.
30. Chesney MA, Ickovics JR, Chambers DB, et al.: Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments. AIDS Care 2000;12(3):255-266.
31. Garcia R, Badaro R, Netto EM, Silva M, Amorin FS, Ramos A, Vaida F, Brites C, and Schooley RT: Cross-sectional study to evaluate factors associated with adherence to antiretroviral therapy by Brazilian HIV-infected patients. AIDS Res Hum Retroviruses 2006;22:1248-1252.
32. Jones SG: Taking HAART: how to support patients with HIV=AIDS. Nursing 2001;31:36-42.
33. Liu C, Johnson L, Ostrow D, et al.: Predictors for lower quality of life in the HAART era among HIV-infected men. J Acquir Immune Defic Syndr 2006;42:470-477. (Pubitemid 44050896)
34. Yang R, Gui X, Zhang Y, and Fu X: Treatment of 41 cases of AIDS with antiretrovirals. Herald Med 2006;25(10):1203-1205.
35. Gao G, Zhang F, Yao J, Zhao H, Lu L, and Li X: Clinical analysis on the relationship between CD4 cell count and opportunity infections. Chin J AIDS=STD 2005;11:241-243.
36. San-Andres FJ, Rubio R, Castilla J, et al.: Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989-1997. Clin Infect Dis 2003;36:1177-1185.
37. Zhang K, Dong P, Qiang L, et al.: Analysis of the incidence of opportunistic infections in relation with the change of CD4P lymphocyte count in people living with HIV=AIDS. Chin J AIDS=STD 2003:9(1):5-7.
38. Koenig SP, Léandre F, and Farmer PE: Scaling-up HIV treatment programmes in resource-limited settings: The rural Haiti experience. AIDS 2004;18:21-25.
39. Coetzee D, Hildebrand K, Boulle A, et al.: Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 2004;18:887-895.
40. Wools-Kaloustian K, Kimaiyo S, Diero L, et al.: Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: Experience from western Kenya. AIDS 2006; 20:41-48.